Flamel Technologies S.A. - Financial and Strategic Analysis Review

Flamel Technologies S.A. - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “Flamel Technologies S.A. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of Flamel Technologies S.A. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Flamel Technologies S.A. (Flamel) is a biopharmaceutical company, developing two polymer-based drug delivery technologies for the improvement of medical applications. The key technologies of the company includes Medusa nanoparticulate technology, Micropump technology and Trigger-Lock technology. The company is developing drugs like Interferon, FT-105 and Interleukin based on its Medusa technology and products like COREG CR, ASACARD and other OTC products based on its Micropump development platform. It secures patents and other intellectual property rights over its innovations and developments and holds 338 patents. The company is headquartered at Venissieux Cedex, France.

Recent Developments

Jul 13, 2009: Baxter, Flamel Sign Collaboration Agreement
Nov 04, 2009: Flamel Licenses Medusa Technology To Pfizer
Nov 04, 2009: Pfizer Exercises Option To License Flamel's Medusa Technology

Scope

• Provides key company information for business intelligence needs
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the company.
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the market opportunities available to them.
• Compare your company’s financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.